Barbara Wirostko

Dr. Wirostko is the Chief Medical Officer and Co-Founder of Qlaris Bio. Dr. Wirostko is a practicing glaucoma specialist and is also a Clinical Adjunct Professor at the University of Utah, Moran Eye Center. She was previously the Chief Medical Officer of EyeGate Pharmaceuticals following its acquisition of Jade Therapeutics where Dr. Wirostko was Co-Founder and Chief Scientific Officer spearheading the development of the Ocular Bandage Gel for human use. Prior to Jade, she served as the Chief Medical Officer of Altheos, a glaucoma company, and held leadership positions in medical and clinical development at Pfizer in Ophthalmology.

Dr. Wirostko received her MD from and completed her residency at Columbia University and holds a BA in Microbiology from Cornell University.